Center InformationMaritza D. Diego BS., PA-C, MMS.
Chief Executive Officer
FXM Clinical Research Miramar,/Francisco Flores, M.D.
14601 SW 29 St., Ste. 208
Miramar, FL 33027
Currently Enrolling Trials
FXM Research is a privately owned and operated clinical research site that conducts phase 1 to 4 clinical research trials specializing in dermatology. Throughout the years, FXM’s ability to deliver aggressive, time-bound enrollment goals, while providing trustworthy data to pharmaceutical companies and CROs, has earned FXM Research a great deal of recognition and fame within the dermatology research industry.
Today, FXM’s success is widely regarded throughout our four operating branches: FXM Clinical Research Miami, based in Miami, Fla., home of our headquarters; FXM Clinical Research Miramar, located in the city of Miramar, Fla.; FXM Clinical Research Ft. Lauderdale, located in Fort Lauderdale, Fla. and FXM Research International, comprised of a Central American branch in Belize City and a Caribbean branch in St. Lucia.
At the core of our business and operating systems, FXM’s mission is to support pharmaceutical companies and CROs in successfully introducing new and approved FDA medications into the marketplace. We perform this efficiently and effectively by providing the highest quality service in a timely fashion and at the lowest possible cost.
- Our primary concerns are subject safety and adherence to the protocol.
- Turnover time for regulatory documents, budgets, and contracts is usually 24 to 48 hours.
- We offer experienced, trained, bilingual (English and Spanish) personnel, who interact with our subjects, sponsors and CROs as a cohesive team.
- Our principal investigators are board-certified dermatologists and certified clinical research investigators with many years of extensive experience. They are located onsite and are available full time.
- Our principal investigators evaluate each and every study subject.
- Most subjects are recruited through advertising and/or from FXM's extensive clinical database. We draw heavily from a Spanish-speaking population, a group often underrepresented in clinical trials.
- We also have continuing extensive experience with a pediatric population.
- We do whatever is necessary to accommodate our subjects' school and/or work schedule, which maximizes compliance and retention.
Since the year 2000, FXM Research’s group of companies has been involved with more than 70 of the most respected pharmaceutical companies and organizations in the world, conducting more than 450 clinical trials in dermatology.
We have acted as a clinical research site in numerous dermatological studies where our normal enrollment consisted of 40-plus subjects with almost 99% compliance from such subjects.
The following are the main therapeutic conditions in dermatology that FXM Research group has conducted studies of:
- Tinea pedis
- Actinic keratosis
- Atopic dermatitis
- Lichen simplex cronicus
- Seborrhoeic dermatitis
- Secondarily infected lesions
- Solar lentignes
- Tinea capitis
- Tinea corporis
- Tinea cruris
- Ichthyosis vulgaris
Our site includes a designated research area with private examining rooms to provide confidentiality and comfort for our subjects. Furthermore, our facility also includes a secured area for studied medications, case report forms, and record storage. A private office is also available to ensure comfortable, peaceful and undistracted monitoring visits for our CRA’s.
Our principal investigator, Francisco Flores MD, is onsite full time. This is because our office houses both our research site and Dr. Flores’s private practice
Our FXM Miramar facility is located 20 miles from Fort Lauderdale International Airport and 18 miles from Miami International Airport
Francisco Flores, MD
FXM Clinical Research Miramar
Dr. Francisco Flores is a board-certified dermatologist with more than 21 years of extensive experience in the field of dermatology. Dr. Flores has conducted more than 126 clinical research trials serving as the principal investigator for FXM Research Miramar. Dr. Flores is an active member of the Association of Clinical Research Professionals (ACRP), the American Society of Dermatologic Surgery and the American Academy of Dermatology. He is also a diplomat of the American Board of Dermatology.
Francisco Moncada, RN, BSN, CCRC
Mr. Moncada, founder of FXM Research, has worked with Dr. Hector Wiltz’s clinical practice for more than 27 years and has extensive experience in most dermatological conditions and disorders. In the year 2000, Mr. Moncada founded his first clinical research site, FXM Research, with operations in Miami, Fla. Today, the site in Miami has conducted more than 218 clinical trials in dermatology under the direction/management of Mr. Moncada and Mrs. Maritza Diego.
To further widen the scope of opportunities FXM Research has to offer to pharmaceuticals and CRO sponsors in the U.S., FXM Research Miramar, with operations in the city of Miramar, Fla., was founded in late 2008. The site is proud to have conducted more 126 studies in dermatology.
In late 2006, after many years of achieving outstanding results conducting clinical trials, Mr. Moncada widened his prospective to the international arena by founding FXM Research International which today consists of two solid, experienced research sites in dermatology located in Belize City and St. Lucas, which together have conducted more than 126 studies in dermatology.
Maritza D. Diego, BS., PA-C, MMS
Chief Operating Officer
Mrs. Diego began her clinical research career at FXM in 2007. Her determination and excellence working successfully in every position within the company has demonstrated her superior understanding for good clinical practice. Her ability to leverage her educational background and extensive experience in clinical research has expanded her knowledge and complete understanding on how to direct/guide any clinical research study.
As the CEO, Mrs. Diego’s job is to handle all regulatory aspects involved in the trials, oversee the success and achievement of all personnel assisting in the trials, and supervise subjects’ conduct during the trials. Mrs. Diego’s management directive is to ensure FXM Clinical Research Miami, Miramar and Ft. Lauderdale deliver the same unequivocal quality of standards for each and every study. Mrs. Diego is certified in HIV/OSHA, CPR, GCP AND IATA regulations.
We are always ranked among the highest enrolling sites in trials we participate in. This is because of our extensive patient/subject database, which consists of FXM’s own extensive clinical research database. Our patient/subject target population consists of the following and includes males and females in all age groups:
Hispanic: 24 percent
Caucasian: 52 percent
African American: 20 percent
Asian: 2 percent
Other: 2 percent
Our subjects give us several reasons why they decide to participate in our clinical research
studies. The ones they most often mention are:
- To help in the development of new medications that may offer better treatment or even cures for chronic diseases;
- The availability of diagnostic tests and medical evaluation of a particular disease or medical condition without worrying about the cost; and
- The hope for a new approach or treatment that finally offers some relief.
For all regulatory issues, we adhere to the assigned CRB.
For all subject database management, we comply with privacy and confidentiality of all HIPAA regulations.
Our clinical research center is located inside the Palm Garden Medical Center on Miramar Parkway. You could access Miramar Parkway (east) exiting I-75 expressway (north or south) on Exit 7. You can access I-75 expressway from either the Florida Turnpike North or from Palmetto Expressway 826 (north or west).